The recent consolidation in Nifty amid weak global cues indicates time-wise correction and traders should maintain a positive bias until the Nifty holds 22,200 level, sayd Ajit Mishra, SVP - Technical Research, Religare Broking.
Gujarat Themis Biosyn Limited informed that the Board of Directors of the Company, at its meeting held on 10th February, 2024, has approved the
an Interim Dividend for the Financial Year 2023-24 of.
Gujarat Themis Biosyn Limited announced that at the board meeting held on February 10, 2024, the company approved an interim dividend for the Financial Year 2023-24 of INR 0.75/- per equity share.
Gujarat Themis Biosyn Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 388.59 million compared.